The markets are in a tailspin due to the ongoing tariff chaos. That’s why, yesterday, I shared the first part of ...
A 40-gene expression profile (40-GEP) test can improve risk stratification of patients with cutaneous squamous cell carcinoma (CSCC), according to research presented at the NCCN Annual Conference 2025 ...
Against this backdrop, high-flying technology stocks that had been big winners for nearly two years collapsed by double digits. The Morningstar US Technology Index fell 12.06%, its worst quarter since ...